This project will use our newly-developed and novel diagnostic tools [computer tomography (CT)-based and electronic health record (EHR)-based] to identify members of the World Trade Center (WTC) General Responder Cohort (GRC) who have evidence of toxicant-associated fatty liver disease (TAFLD) and liver cancer. The findings will provide unprecedented detail about these occupational liver diseases, helping to inform public policy. A WTC Liver Disease registry will be established to collect data about the impact of liver disease on quality of life and other valuable information.
Study Design: Case-Control
No publications available at this time.